Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes

Journal of Internal Medicine

Volumn 252, Issue 4, 2002, Pages 342-351

  Sjoberg S ^a   Ahren B ^b   Bolinder, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adrenaline; C peptide excretion; Glucagon; Glucose counter regulation; Pancreatic polypeptide

Indexed keywords

C PEPTIDE; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN; PANCREAS POLYPEPTIDE;

ADRENALIN BLOOD LEVEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; STANDARDIZATION;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; C-PEPTIDE; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCAGON; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PANCREATIC POLYPEPTIDE; RADIOIMMUNOASSAY; TIME FACTORS;

EID: 0036032975     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.01043.x     Document Type: Article

References (39)

1. Amiel SA, Tamborlane WV, Saccà L, Sherwin RS. Hypoglycaemia and glucose counter-regulation in normal and insulin-dependent diabetic subjects. Diabetes Metab Rev 1988; 4: 71-89.
2. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha-cell defect. Science 1973; 182: 171-3.
3. Bolli G, DeFeo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes; 198: 134-41.
4. Shilo S, Sotsky M, Shamoon H. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. J Clin Endocrinol Metab 1990; 70: 162-72.
5. Raskin P, Aydin I, Unger RH. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus. Diabetes 1976; 25: 227-9.
6. Fukuda M, Tanaka A, Tahara Y et al. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 1988; 37: 81-8.
7. The Diabetes Control and Complications Trial Research Group. Hypoglycaemia in the diabetes control and complications trial. Diabetes 1997; 46: 271-86.
8. Bott S, Bott U, Berger M, Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997; 40: 926-32.
9. Mühlhauser I, Overmann H, Bender R, Bott U, Berger M. Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes-a prospective population based study. Diabetologia 1998; 41: 1274-82.
10. Havel PJ, Akpan JO, Curry DL, Stern JS, Gingerich RL, Ahrén B. Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglycopenia and hypoglycaemia in mice. Am J Physiol 1993; 265: R246-54.
11. Havel PJ, Ahrén B. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women. Diabetes 1997; 46: 801-7.
12. Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert AK, Persson A, Östman J. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term Type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30: 208-13.
13. Sjöberg S, Gjötterberg M, Berglund L, Möller E, Östman J. Residual C-peptide excretion is associated with a better long-term glycaemic control and slower progress of retinopathy in Type 1 (insulin-dependent) diabetes mellitus. J Diabetic Compl 1991; 5: 18-22.
14. McGuire EAH, Helderman JH, Tobin JD, Andres R, Bergman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976; 41: 565-73.
15. Kaddish AH, Little RL, Sternberg JC. A new and rapid method for the determination of glucose by measurements of the rate of oxygen consumption. Clin Chem 1968; 14: 116-31.
16. Hallman H, Farnebo LE, Hamberg B, Jonsson G. A sensitive method for determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci 1978; 23: 1049-52.
17. Kuzuya M, Blix PM, Horowitz OL, Steiner DF, Rubenstein AH. Determinations of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 1977; 26: 22-9.
18. Cerasi E, Della Casa L, Luft R, Roovete A. Determination of human human growth hormone (HGH) in plasma by double antibody raioimmunoassay. Acta Endocrinol (Copenh) 1966; 53: 101-20.
19. Lantto O, Lindbäck B, Aakvaag A, Damkjaer-Nilsen M, Pomoell V-M, Björkhem I. Assay of cortisol with radioimmunoassay method calibrated by isotope dilution-mass spectrometry. A nordic colloborative. Scand J Clin Invest 1983; 43: 433-7.
20. Faloona FR, Unger RH. Glucagon. In: Jaffe BM, Behrman HR, eds. Methods of Hormone Radioimmunoassay. New York: Academic Press, 1974; 317-30.
21. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541-8.
22. Groth CG, Andersson A, Björkén C et al. Attempts at transplantation of fetal pancreas to diabetic patients. Transpl Proc 1980; 12 (Suppl. 2): 208-12.
23. Laron Z, Aurbach-Klipper Y, Flasterstein B, Litwin A, Dickerman Z, Heding LG. Changes in endogenous insulin secretion during childhood as expressed by plasma and urinary C-peptide. Clin Endocrinol 1988; 29: 625-32.
24. Maher TD, Tanenberg RJ, Greenberg BZ, Hoffman JE, Doe RP, Goetz FC. Lack of glucagon response to hypoglycaemia in diabetic neuropathy. Diabetes 1976; 26: 196-200.
25. Fery F, Plat L, van de Borne P, Cogan E, Mockel J. Impaired counter-regulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med 1999; 340: 852-6.
26. Taborsky GJ, Ahren B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998; 47: 995-1005.
27. Hilsted J, Madsbad S, Kararup T et al. No response of pancreatic hormones to hypoglyaemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1982; 54: 815-9.
28. Kennedy FP, Go VL, Cryer PE, Bolli GB, Gerich JE. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy. Ann Intern Med 1988; 108: 54-8.
29. White NH, Gingerich RL, Levandoski LA, Cryer PE, Santiago JV. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counteregulation in insulin-dependent diabetes mellitus. Diabetes 1985; 34: 870-5.
30. Cryer PE. Glucose counter-regulation: The prevention and correction of hypoglycemia in humans. Am J Physiol 1993; 264: E149-E155.
31. Ziegler D, Gries FA, Spuler M, Lessman L. The epidemiology of diabetes neuropathy. J Diab Compl 1992; 6: 49-57.
32. Dagogo-Jack SE, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defence against subsequent hypoglycemia. J Clin Invest 1993; 91: 819-28.
33. Liu D, Moberg E, Kollind M, Lins PE, Adamson U. A high concentration of circulating insulin supress the glucagon response to hypoglycaemia in normal man. J Clin Endocrinol Metab 1991; 73: 1123-8.
34. Liu D, Adamson UC, Lins PE, Kollind ME, Moberg EA, Andreasson K. Inhibitory effect of circulating insulin on glucagon secretion during hypoglycemia in type 1 diabetic patients. Diabetes Care 1992; 15: 59-65.
35. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, cathecholamines and growth hormone in human glucose counter-regulation. Effects of somatostatin and combined alpha- and beta-blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycaemia. J Clin Invest 1979; 64: 62-71.
36. Sundkvist G, Tydén G, Karlsson FA, Bolinder J. Islet autoimmunity before and after pancreas transplantation in patients with type 1 diabetes mellitus. Diabetologia 1998; 41: 1532-3.
37. Borg H, Marcus C, Sjöblad S, Fernlund P, Sundkvist G. Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies /1, A2 anttibodies after diagnosis of diabetes. Acta Paediatr 2000; 89: 46-51.
38. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-years prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51: 1754-62.
39. Tillil H, Shapiro ET, Given BD et al. Reevaluation of urine C-peptide as measure of insulin secretion. Diabetes 1988; 37: 1195-201.